Equaten
Alternative Names: RL 6134Latest Information Update: 16 Jan 2019
At a glance
- Originator Aventis
- Class Antihypertensives; Small molecules
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 26 Apr 1995 Discontinued-Preclinical for Hypertension in USA (Unknown route)